MedPath

河北爱尔海泰制药有限公司

Ownership
-
Established
2006-03-07
Employees
-
Market Cap
-
Website
aierhaitai.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

NMPA:42

Drug Approvals

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20093457
Approval Date
Sep 18, 2023
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20093459
Approval Date
Jul 21, 2023
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20093458
Approval Date
Jul 6, 2023
NMPA

Naloxone Hydrochloride Injection

Product Name
盐酸纳洛酮注射液
Approval Number
国药准字H20093460
Approval Date
Jul 6, 2023
NMPA

Naloxone Hydrochloride for Injection

Product Name
注射用盐酸纳洛酮
Approval Number
国药准字H20080570
Approval Date
May 4, 2023
NMPA

Lomefloxacin Aspartate Injection

Product Name
门冬氨酸洛美沙星注射液
Approval Number
国药准字H20067318
Approval Date
Mar 23, 2023
NMPA

Rifapentine Capsules

Product Name
利福喷丁胶囊
Approval Number
国药准字H20133047
Approval Date
Jul 28, 2022
NMPA

Compound Vitamines for Injection (3)

Product Name
注射用复方维生素(3)
Approval Number
国药准字H20130005
Approval Date
Jul 28, 2022
NMPA

热淋清片

Approval Number
国药准字Z20060256
Approval Date
Oct 13, 2021
NMPA

Acelglutamide for Injection

Product Name
赫迪新
Approval Number
国药准字H20050408
Approval Date
Jun 22, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.